Road map for fibrolamellar carcinoma: progress and goals of a diversified approach.

Kastenhuber, Edward R; Craig, John; Ramsey, Jon; Sullivan, Kevin M; Sage, Julien; de Oliveira, Sofia; Riehle, Kimberly J; Scott, John D; Gordan, John D; Bardeesy, Nabeel; Abou-Alfa, Ghassan K

Kastenhuber, Edward R; Craig, John; Ramsey, Jon; Sullivan, Kevin M; Sage, Julien; de Oliveira, Sofia; Riehle, Kimberly J; Scott, John D; Gordan, John D; Bardeesy, Nabeel; Abou-Alfa, Ghassan K.

Afiliación

Kastenhuber ER; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA, abou-alg@mskcc.org.
Craig J; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ramsey J; Fibrolamellar Cancer Foundation, Greenwich, CT, USA.
Sullivan KM; Department of Biochemistry, University of Vermont Cancer Center, Burlington, VT, USA.
Sage J; Northwest Liver Research Program, University of Washington, Seattle, WA, USA.
de Oliveira S; Department of Pediatrics, Stanford University, Stanford, CA, USA.
Riehle KJ; Department of Genetics, Stanford University, Stanford, CA, USA.
Scott JD; Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, WI, USA.
Gordan JD; Northwest Liver Research Program, University of Washington, Seattle, WA, USA.
Bardeesy N; Northwest Liver Research Program, University of Washington, Seattle, WA, USA.
Abou-Alfa GK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

J Hepatocell Carcinoma ; 6: 41-48, 2019.

Article en En | MEDLINE | ID: mdl-30951568

Palabras clave

adolescent; cyclic AMP-dependent protein kinase catalytic subunit; fibrolamellar carcinoma; fusion oncogene; heat shock protein 40; liver cancer; young adult

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google